- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT00332098
Effectiveness of Family-Focused Treatment Plus Pharmacotherapy for Bipolar Disorder in Adolescents
Family-Focused Treatment for Bipolar Adolescents
Visão geral do estudo
Status
Condições
Descrição detalhada
Bipolar disorder is a serious mental illness that causes drastic shifts in a person's mood, energy, and ability to function. Bipolar disorder can strike at any age, but it most commonly develops in late adolescence or early adulthood. The disorder is characterized by alternating episodes of mania and depression, often with periods of normal mood in between. Some symptoms of a manic episode include the following behaviors: increased energy, activity, and restlessness; excessively "high," overly good, euphoric mood; and extreme irritability. In contrast, a depressive episode is characterized by a lasting sad, anxious, or empty mood; feelings of hopelessness or pessimism; and decreased energy. Adolescents with bipolar disorder have high rates of disease recurrence, suicide attempts, functional impairment, and mental health service utilization, even with aggressive treatment with mood stabilizers and antipsychotic drugs. Research has suggested that FFT, a behavioral intervention consisting of psychoeducation, communication training, and problem solving training, may lead to improvements in mood symptoms in adolescents with bipolar disorder. This study will evaluate the effectiveness of FFT plus pharmacotherapy in treating adolescents with bipolar illness.
Participants in this 2-year, single-blind study will be randomly assigned to receive a combination of either FFT and pharmacotherapy or enhanced care and pharmacotherapy. Medications used for the pharmacotherapy portion of the study will include mood stabilizers, such as lithium or divalproex sodium, and atypical antipsychotics, such as quetiapine. Participants will also receive anti-anxiety medications, psychostimulants, or antidepressants as needed. All participants will receive pharmacotherapy for the full 2 years. Participants assigned to enhanced care will take part in weekly brief psychoeducation sessions for 3 weeks. Participants assigned to FFT will take part in weekly treatment sessions with their families for 12 weeks, biweekly for 12 weeks, monthly for 3 months, and then trimonthly until Month 24. Both FFT and enhanced care treatment sessions will include psychoeducation focusing on appropriate ways to manage bipolar disorder and its cycling nature. Crisis intervention sessions will also be offered to all participants on an as-needed basis for the duration of the study. Outcomes, including bipolar disorder symptoms, functioning, and service utilization, will be measured at study visits at Months 3, 6, 9, 12, 18, and 24.
Tipo de estudo
Inscrição (Real)
Estágio
- Fase 3
Contactos e Locais
Locais de estudo
-
-
Colorado
-
Boulder, Colorado, Estados Unidos, 80309-0345
- University of Colorado, Dept. of Psychology
-
-
Ohio
-
Cincinnati, Ohio, Estados Unidos, 45229
- Cincinnati Children's Hospital Medical Center/MLC 3014
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, Estados Unidos, 15213
- University of Pittsburgh Medical Center Western Psychiatric Institute
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Between the ages of 13 years, 0 months and 17 years, 11 months
- Meets The Diagnostic and Statistical Manual of Mental Disorders - IV criteria for either of the following conditions: bipolar I or bipolar II disorder with a manic, mixed, or hypomanic episode within 3 months of study entry; or a depressed episode within 3 months of study entry with a prior history of a manic, hypomanic, or mixed episode (if the participant only meets criteria for a current hypomanic episode, there must also be a history of at least one prior depressive, manic, or mixed episode)
- Has experienced severe depression, hypomania, or mania symptoms for a period of at least 1 week within the 3 months prior to study entry
- Lives with at least one biological or step-parent who is available and willing to participate in treatment (parents not currently living with the adolescent participant may also participate)
Exclusion Criteria:
- Currently in full recovery (experienced minimal symptoms for at least 8 continuous weeks)
- Meets Diagnostic and Statistical Manual of Mental Disorders, IV criteria for substance abuse disorder or substance dependence disorder within 3 months of study entry (based on the Kiddie Schedule for Affective Disorders and Schizophrenia - Present and Lifetime Version )
- Meets current criteria for bipolar, not otherwise specified, or substance-induced mood disorder
- Diagnosis of mental retardation, autism, or organic central nervous system disorder
- Severe, unremitting psychosis that is unresponsive to neuroleptic medications, and has lasted more than 3 months
- Requires extended inpatient treatment (although participant can be hospitalized at the time of intake into the study)
- Current life-threatening eating disorder, neurological condition, or other medical problem that requires immediate treatment
- Exhibits or expresses serious homicidal tendencies
- Victim of current sexual or physical abuse by parents or is in an environment marked by domestic violence among the parents or step-parents
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
---|---|
Experimental: 1
Family-Focused Treatment Plus Pharmacotherapy
|
Participants assigned to FFT will take part in weekly treatment sessions with their families for 12 weeks, biweekly for 12 weeks, monthly for 3 months, and then trimonthly until Month 24.
Medications used for the pharmacotherapy portion of the study will include mood stabilizers, such as lithium or divalproex sodium, and atypical antipsychotics, such as quetiapine.
Participants will also receive anti-anxiety medications, psychostimulants, or antidepressants as needed.
|
Comparador Ativo: 2
Enhanced Care Plus Pharmacotherapy
|
Participants assigned to Enhanced Care will take part in weekly brief psychoeducation sessions for 3 weeks.
The pharmacotherapy treatment will be the same as for the FFT participants.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Prazo |
---|---|
Time to recovery
Prazo: Measured at Month 24
|
Measured at Month 24
|
Time to recurrence
Prazo: Measured at Month 24
|
Measured at Month 24
|
Severity of manic and depressive symptoms
Prazo: Measured at Month 24
|
Measured at Month 24
|
Medidas de resultados secundários
Medida de resultado |
Prazo |
---|---|
Functioning
Prazo: Measured at Month 24
|
Measured at Month 24
|
Quality of life
Prazo: Measured at Month 24
|
Measured at Month 24
|
Service utilization
Prazo: Measured at Month 24
|
Measured at Month 24
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: David J. Miklowitz, PhD, University of Colorado at Boulder
- Investigador principal: Robert A. Kowatch, MD, University of Cincinnati
- Investigador principal: David A. Axelson, MD, University of Pittsburgh Medical Center
Publicações e links úteis
Publicações Gerais
- Miklowitz DJ, George EL, Axelson DA, Kim EY, Birmaher B, Schneck C, Beresford C, Craighead WE, Brent DA. Family-focused treatment for adolescents with bipolar disorder. J Affect Disord. 2004 Oct;82 Suppl 1(Suppl 1):S113-28. doi: 10.1016/j.jad.2004.05.020.
- Miklowitz DJ, Axelson DA, Birmaher B, George EL, Taylor DO, Schneck CD, Beresford CA, Dickinson LM, Craighead WE, Brent DA. Family-focused treatment for adolescents with bipolar disorder: results of a 2-year randomized trial. Arch Gen Psychiatry. 2008 Sep;65(9):1053-61. doi: 10.1001/archpsyc.65.9.1053.
- Miklowitz DJ, Schneck CD, George EL, Taylor DO, Sugar CA, Birmaher B, Kowatch RA, DelBello MP, Axelson DA. Pharmacotherapy and family-focused treatment for adolescents with bipolar I and II disorders: a 2-year randomized trial. Am J Psychiatry. 2014 Jun;171(6):658-67. doi: 10.1176/appi.ajp.2014.13081130.
- O'Donnell LA, Weintraub MJ, Ellis AJ, Axelson DA, Kowatch RA, Schneck CD, Miklowitz DJ. A Randomized Comparison of Two Psychosocial Interventions on Family Functioning in Adolescents with Bipolar Disorder. Fam Process. 2020 Jun;59(2):376-389. doi: 10.1111/famp.12521. Epub 2020 Feb 3.
- Weintraub MJ, Schneck CD, Axelson DA, Birmaher B, Kowatch RA, Miklowitz DJ. Classifying Mood Symptom Trajectories in Adolescents With Bipolar Disorder. J Am Acad Child Adolesc Psychiatry. 2020 Mar;59(3):381-390. doi: 10.1016/j.jaac.2019.04.028. Epub 2019 May 28.
- O'Donnell LA, Axelson DA, Kowatch RA, Schneck CD, Sugar CA, Miklowitz DJ. Enhancing quality of life among adolescents with bipolar disorder: A randomized trial of two psychosocial interventions. J Affect Disord. 2017 Sep;219:201-208. doi: 10.1016/j.jad.2017.04.039. Epub 2017 Apr 28.
- Keenan-Miller D, Peris T, Axelson D, Kowatch RA, Miklowitz DJ. Family functioning, social impairment, and symptoms among adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2012 Oct;51(10):1085-94. doi: 10.1016/j.jaac.2012.08.005. Epub 2012 Aug 28.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Estimativa)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- R01MH073871 (Concessão/Contrato do NIH dos EUA)
- DSIR 84-CTS (Division of Services and Intervention Research)
- R01MH073817 (Concessão/Contrato do NIH dos EUA)
- R01MH074033 (Concessão/Contrato do NIH dos EUA)
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Transtorno bipolar
-
ProgenaBiomeRecrutamentoTranstorno bipolar | Transtorno Bipolar I | Transtorno Bipolar II | Transtorno Bipolar Tipo I | Transtorno Bipolar Leve | Transtorno Bipolar Moderado | Transtorno Bipolar GraveEstados Unidos
-
University of PittsburghNational Alliance for Research on Schizophrenia and DepressionConcluídoTranstorno Bipolar I | Transtorno Bipolar II | Transtorno Bipolar SOEEstados Unidos
-
Region StockholmKarolinska InstitutetRecrutamentoTranstorno bipolar | Depressão bipolar | Transtorno Bipolar I | Transtorno Bipolar II | Transtorno Afetivo Bipolar; Remissão em | Transtorno Afetivo Bipolar, Atualmente Deprimido, ModeradoSuécia
-
Joshua RosenblatRecrutamentoTranstorno bipolar | Depressão bipolar | Transtorno Bipolar I | Transtorno Bipolar IICanadá
-
National Human Genome Research Institute (NHGRI)ConcluídoTranstorno Bipolar (DB) | BipolarEstados Unidos
-
Joshua RosenblatRecrutamentoTranstorno bipolar | Depressão bipolar | Transtorno Bipolar I | Transtorno Bipolar IICanadá
-
Rush University Medical CenterThe Ryan Licht Sang Bipolar FoundationConcluídoTranstorno bipolar | Depressão bipolar | Transtorno Bipolar I | Transtorno Bipolar I | Transtorno Afetivo BipolarEstados Unidos
-
University Health Network, TorontoConcluídoTranstorno bipolar | Depressão bipolar | Depressão Bipolar I | Depressão Bipolar IICanadá
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do Sul; Hospital Moinhos de VentoAtivo, não recrutandoTranstorno bipolar | Depressão bipolar | Transtorno Depressivo Maior | Transtorno Bipolar I | Transtorno afetivo | Transtorno Bipolar IIBrasil
-
Medical University of South CarolinaMilken InstituteConcluídoTranstorno bipolar | Transtorno Bipolar I | Transtorno Bipolar IIEstados Unidos